StoxApollo Hospitals Enterprise vs Mankind Pharma: share price & financials comparison
NSE: APOLLOHOSP vs MANKIND · Healthcare · as of 13 Nov 2026
Both prices rebased to 100 at the start of the selected period.
Apollo Hospitals Enterprise vs Mankind Pharma at a glance
Apollo Hospitals Enterprise (APOLLOHOSP) has a market capitalisation of ₹1,22,604 Cr, against ₹1,09,032 Cr for Mankind Pharma (MANKIND). Over the past year Mankind Pharma has returned +11.4%, compared with +9.2% for Apollo Hospitals Enterprise. On valuation, Mankind Pharma trades at a lower P/E of 48.5 versus 54.7. Apollo Hospitals Enterprise earns a higher return on equity (21.1% vs 12.8%). Apollo Hospitals Enterprise comes out ahead on size and growth. Mankind Pharma comes out ahead on valuation, profitability, financial health, momentum and technicals. Across the scored metrics below, Apollo Hospitals Enterprise leads on 6 and Mankind Pharma on 10. On StoxGud's 10-point checklist, Apollo Hospitals Enterprise scores 7/10 and Mankind Pharma scores 7/10.
| Metric | Apollo Hospitals Enterprise | Mankind Pharma |
|---|---|---|
| Size | ||
| Market cap | ₹1,22,604 Cr | ₹1,09,032 Cr |
| Revenue (latest FY) | ₹25,228 Cr | ₹14,278 Cr |
| Net profit (latest FY) | ₹1,942 Cr | ₹1,913 Cr |
| Valuation | ||
| P/E | 54.7 | 48.5 |
| P/B | 11.56 | 6.20 |
| Dividend yield | 0.24% | 0.04% |
| Profitability | ||
| Return on equity | 21.1% | 12.8% |
| Net profit margin | 8.1% | 14.6% |
| Operating margin | 15.4% | 26.5% |
| Growth | ||
| Revenue growth (YoY) | +20.8% | +17.3% |
| Net profit growth (YoY) | +32.0% | +39.1% |
| Revenue CAGR (multi-year) | +19.0% | +17.7% |
| Financial health | ||
| Debt to equity | 0.53 | 0.31 |
| Momentum | ||
| 1-month return | +8.3% | +11.3% |
| 1-year return | +9.2% | +11.4% |
| 3-year CAGR | +17.8% | +12.9% |
| 5-year CAGR | +10.9% | — |
| 10-year CAGR | +21.8% | — |
| Distance from 52W high | -6.0% | -1.1% |
| Technicals | ||
| RSI (14) | 75 | 84 |
| Price vs 200-day avg | +4.6% | +13.3% |
Highlighted cells lead on that metric. Market cap, revenue and RSI are shown for context and not scored.
10-point checklist side by side
| Check | Apollo Hospitals Enterprise | Mankind Pharma |
|---|---|---|
| Price above 50-day average | ✓ | ✓ |
| Price above 200-day average | ✓ | ✓ |
| 50-day average above 200-day (uptrend) | ✓ | ✓ |
| RSI in healthy 40–70 zone | ✗ | ✗ |
| Positive 1-year return | ✓ | ✓ |
| Return on equity above 15% | ✓ | ✗ |
| Debt to equity below 1 | ✓ | ✓ |
| Revenue growing year on year | ✓ | ✓ |
| Net profit margin above 10% | ✗ | ✓ |
| P/E below industry median | ✗ | ✗ |
| Score | 7/10 | 7/10 |
A rules-based screen for education only — not a buy or sell recommendation.
FAQs
Which is bigger, Apollo Hospitals Enterprise or Mankind Pharma?
Apollo Hospitals Enterprise has a market cap of ₹1,22,604 Cr and Mankind Pharma has a market cap of ₹1,09,032 Cr as of 13 Nov 2026.
Which has a lower P/E, Apollo Hospitals Enterprise or Mankind Pharma?
Mankind Pharma has the lower P/E: Apollo Hospitals Enterprise trades at 54.7 and Mankind Pharma at 48.5.
Which gave better returns in the last year, Apollo Hospitals Enterprise or Mankind Pharma?
Mankind Pharma did better: Apollo Hospitals Enterprise returned +9.2% and Mankind Pharma returned +11.4% over one year.
What is the difference between Apollo Hospitals Enterprise and Mankind Pharma?
Both are NSE-listed companies in Healthcare. They are about the same size by market cap (₹1,22,604 Cr vs ₹1,09,032 Cr). In the latest financial year Apollo Hospitals Enterprise reported revenue of ₹25,228 Cr and Mankind Pharma ₹14,278 Cr. Operating margin is 15.4% for Apollo Hospitals Enterprise and 26.5% for Mankind Pharma. Debt to equity is 0.53 for Apollo Hospitals Enterprise and 0.31 for Mankind Pharma.
Which is better, Apollo Hospitals Enterprise or Mankind Pharma?
It depends on what you are looking for, and StoxGud does not recommend either stock. On the metrics compared above, Apollo Hospitals Enterprise leads on 6 and Mankind Pharma on 10. Apollo Hospitals Enterprise is ahead on size and growth. Mankind Pharma is ahead on valuation, profitability, financial health, momentum and technicals. On StoxGud's rules-based checklist Apollo Hospitals Enterprise scores 7/10 and Mankind Pharma scores 7/10. This is information, not advice: consult a SEBI-registered adviser before investing.